Trust Company of Vermont Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$10.5M |
| 2 |
Vanguard Health Care ETF
VHT
|
+$9.3M |
| 3 |
Microsoft
MSFT
|
+$4.67M |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$4.28M |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
+$4.09M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$2.52M |
| 2 |
Pfizer
PFE
|
+$2.29M |
| 3 |
Starbucks
SBUX
|
+$1.95M |
| 4 |
MSC Industrial Direct
MSM
|
+$1.74M |
| 5 |
Comcast
CMCSA
|
+$1.69M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.01% |
| 2 | Financials | 13.72% |
| 3 | Healthcare | 10.59% |
| 4 | Consumer Discretionary | 9.17% |
| 5 | Industrials | 8.49% |
Similar funds
Trust Company of Vermont's Q4 2024 Portfolio in Review
As of Q4 2024, Trust Company of Vermont held 1,145 positions worth $2.06B, up 3.2% from $2B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Trust Company of Vermont deployed $72.4M of net new capital in Q4 2024, opening 81 new positions and adding to 230 existing holdings. Its largest new stake was Vanguard Health Care ETF: 34,511 shares worth $8.76M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was CVS Health, an estimated $2.52M trimmed.
- Trust Company of Vermont's largest Q4 2024 buy was Vanguard Health Care ETF: 34,511 shares worth $8.76M.
- Trust Company of Vermont added most to Vanguard S&P 500 ETF in Q4 2024, an estimated $10.5M increase.
- Trust Company of Vermont's biggest Q4 2024 reduction was CVS Health, cutting an estimated $2.52M.
- Trust Company of Vermont fully exited Schwab U.S Small- Cap ETF in Q4 2024, selling an estimated $84.4K.
- Trust Company of Vermont's ten largest holdings make up 31% of its $2.06B portfolio in Q4 2024.
- Trust Company of Vermont opened 81 new positions and closed 93 in Q4 2024.
- Trust Company of Vermont's portfolio value rose 3.2% quarter-over-quarter to $2.06B.
Based on Trust Company of Vermont's 13F filing for Q4 2024, filed 15 Jan 2025.